Prevalence of Fluoroquinolone Resistant Escherichia coli in Patients Undergoing Transrectal Prostate Biopsy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210824004

Enrollment

140

Registered

2021-08-24

Start date

2021-10-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post transrectal biopsy of prostate biopsy infectious complication transrectal biopsy of prostate biopsy , infectious complication

Interventions

rectal swab for Fluoroquinolone Resistant Escherichia coli in Patients Undergoing Transrectal Prostate Biopsy

Experimental Other

RECTAL SWAB

Eligibility

Sex/Gender

Male

Age

36 Years to No maximum

Inclusion criteria

Inclusion criteria: Male undergoing transrectal biopsy of prostate

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Prevalence Fluoroquinolone Resistant Escherichia coli in Patients Undergoing Transrectal Prostate Biopsy 1 month Prevalence	—

Secondary

Measure	Time frame
Post TRUS-Biopsy of prostate complication rate 1 month complication rate	—

Countries

Thailand

Contacts

Public Contactkantapon tangwiwat

faculty of medicine chulalongkorn university

kantapontang@gmail.com0895408016

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026